Glucose Noridem

Glucose Noridem is an intravenous solution that contains the active ingredient glucose monohydrate. It is supplied as a sterile parenteral nutrition formulation without a specified strength. The product is marketed in the European Union and is available by prescription only. As an excipient and solvent, it delivers glucose directly into the bloodstream for energy provision and osmotic balance in hospitalized patients during clinical care settings.

Glucose Noridem is used as part of intravenous therapy to support patients who cannot receive nutrition orally.

- Provides a source of glucose for parenteral nutrition in patients requiring total or supplemental intravenous feeding. - Treats acute hypoglycemia when rapid elevation of blood glucose is needed. - Assists in fluid and electrolyte replacement by contributing to osmotic load. - Supports metabolic needs during perioperative or critical‑care management. - Can be combined with other intravenous nutrients to formulate customized nutrition admixtures.

Adverse reactions to Glucose Noridem are generally related to the intravenous administration of a glucose solution.

Common: - Local irritation or pain at the infusion site. - Mild hyperglycemia reflected by transiently elevated blood glucose levels. - Electrolyte shifts, particularly mild hyponatremia or hypokalemia. - Nausea or mild gastrointestinal discomfort.

Serious: - Severe hyperglycemia with risk of osmotic diuresis. - Fluid overload leading to pulmonary edema in susceptible patients. - Allergic reactions such as urticaria, angioedema, or anaphylaxis. - Metabolic acidosis in patients with impaired glucose utilization.

When prescribing Glucose Noridem, clinicians should evaluate patient-specific factors and monitor relevant parameters.

- Verify blood glucose levels before and during infusion to avoid excessive hyperglycemia. - Assess fluid status and cardiac function to prevent volume overload. - Adjust dosage in patients with renal or hepatic impairment due to altered glucose metabolism. - Use caution in diabetic patients and those receiving other dextrose-containing solutions. - Monitor electrolytes, especially sodium and potassium, during prolonged therapy. - Consider contraindication in patients with known hypersensitivity to glucose monohydrate.

Glucose Noridem may interact with other intravenous agents or systemic medications.

Avoid: - Co‑administration with high‑dose insulin infusions without appropriate glucose monitoring. - Simultaneous infusion of other hyperosmolar dextrose solutions that could cause severe hyperglycemia. - Use with medications that significantly raise serum potassium, increasing risk of hyperkalemia. - Concurrent infusion of sodium bicarbonate solutions, which may increase osmolar load.

Use with caution: - Concurrent administration of diuretics, which may alter fluid balance. - Combination with corticosteroids, which can exacerbate hyperglycemia. - Concurrent use of beta‑adrenergic agonists that may affect glucose metabolism. - Co‑administration with thiazide diuretics, which can impair glucose tolerance.